Article Sidebar

Submitted
July 23, 2021
Published
July 23, 2021
Download
PDF
Statistic
Read Counter : 427 Download : 0

Main Article Content

Abstract

ABSTRACT To produce an effect, the agonist drug ï¢2 will bind to the ADRB2 receptor. The effect of agonist ï¢2 shows variation between individuals due to the presence of encoding gene polymorphisms. There are 80 ADRB2 polymorphisms, including Arg16Gly in amino acids 16. The innate ADRB2 genotype is called wildtype, whereas mutated ones is called mutant. The purpose of this study was to determine whether there was a relationship between genotype rs 1042713 (Arg16Gly) and the effectiveness of β2-agonist drugs in asthma sufferers. This study was an observational study with a cross sectional design and prospective data collection. Examination of the presence of gene polymorphisms and assessment of effe A total of 101 asthma patients who met the inclusion criteria were sorted by genome type by pharmacogenomic examination uses the Asthma Control Test (ACT) questionnaire. The results of the statistical test with chi square to determine the relationship of genome type and asthma control obtained p value 0.131. The comparison of the effectiveness of the wildtype genome is more effective than the mutant of 1.887x, and heterozygote is more effective 1,667x greater than the mutant. There is no significant relation between genotypes rs 1042713 (Arg16Gly) with effectiveness, but the possibility of clinical effectiveness is different. Keywords: Asthma, β2-agonist, ADRB2, genotype, effectiveness.

Article Details

References

  1. Andayani, N dan Waladi Z. 2014, Hubungan tingkat pengetahuan pasien asma dengan tingkat kontrol asma di poliklinik paru RSUD DR. Zainoel Abidin Banda Aceh. Jurnal Kedokteran Syiah Kuala, 14(3):139–45.
  2. Birbian N, Singh J, Jindal S, dan Singia N, 2012. Association of B2-Adrenergic Receptor Polymorphisms with Asthma in a North Indian Population. Lung, 190: 497–504.
  3. Bleecker, E.R., Yancey,S.W., Baitinger, L.A., Edwards, L.D., Klotsman, M., Anderson, W.H., dan Dorinsky, P.M, 2006, Salmeterol response is not affected by β2-Adrenergic receptor genotype in subjects with persistent asthma, J Allergy Clin Immunol, 118(4), 809-816
  4. Global Initiative for Asthma (GINA), 2017. Pocket Guide for Asthma Management and Prevention (for Adult and Children Older than 5 Years), diperoleh melalui situs internet: http://www.ginasthma.or. Diunduh pada tanggal 27 September 2017.
  5. Green, S.A., Turki, J., Bejarano, P., Hall, J.P., dan Ligget, S.B., 1995, Influence of beta2-adrenergic genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol
  6. Biol, 13:25-33
  7. Hall, IP, 2006. Pharmacogenetics. Taylor & Francis, New York.
  8. Hakim, L, 2012. Farmakokinetika Klinik. Bursa Ilmu, Yogyakarta.
  9. Hubungan Genotipe rs 1042713 (Arg16Gly) Dengan Efektivitas β2-Agonis Pada Penderita Asma (Sri Haryanti) Haryanti, S., Ikawati, Z., Andayani, T.M, dan Mustofa, 2016, Hubungan kepatuhan menggunakan obat inhaler β2-Agonis dan control asma pada pasien asma. Jurnal Farmasi Klinik Indonesia, 5(4), 238-248.
  10. Israel, E., Chinchilli, V.M., Ford, J.G., Boushey, H.A., Cherniack. R., dan Craig, T.J., 2004, Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebocontrolled cross-over trial, Lancet, 364:1505-12.
  11. Kementrian Kesehatan RI, 2018. Riset Kesehatan Dasar Riskesdas 2018. Kemenkes RI, Jakarta Kobilka, B., Dixon, R., Frielle, T., 1995, cDNA for the human b2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proceedings of the National Academy of Sciences of the United States of America, 84: 46–50.
  12. Krukreti, R., Bhatnagar, P., B-Rao. C, Gupta, S., Madan, B., Das, C. Guleria, R., Athavale, A.U., Brahmachari, S.K., Ghosh, B., 2005, Beta (2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatic. Pharmacogenomics;6(4), 399-410.
  13. Lee, D., Currie, G., Hall, I., Lima, J., Lipworth, B., 2004, The arginine-16 beta2-adrenoceptor polymorphism predisposes to ronchoprotective subsensitivity in patients treated with formoterol and salmeterol. Br J Clin Pharmacol, 57(1), 68-75.
  14. Lim dan Kobzik, 2008, Sexual tension in the airways: the puzzling duality of estrogen in asthma. American Journal of Respiratory Cell and Molecular Biology, 38, 499-500
  15. Litonjua, A.A., Gong, L., Duan, Q.L., Shin, J., Moore, M.J., Weissa, S.T., Johnsone, J.A., Kleinb, T.E., dan Altmanb, R.B., 2010, Very important pharmacogene summary ADRB2, Pharmacogenetics and Genomics, 20(1), 64–69.
  16. Marco, R., Locatelli, F., Sunyer, J., Burney, P., 2000. Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey. Am J Respir Care Med, 162(1), 68–74.
  17. McGraw, D., Almoosa K, Paul, R., Kobilka, B., Liggett, S., 2003, ntithetic regulation by - adrenergic receptors of G q receptor signaling via phospholipase C underlies the airway - agonist paradox, J Clin Invest, 112(4), 619-26.
  18. Postma, D., Meyers, D., Jongepier, H., Howard, T., Koppelman, G., dan Bleecker, E., 2005, Genomewide screen for pulmonary function in 200 families ascertained for asthma. American Journal of Respiratory and Critical Care Medicine,172, 446–452.
  19. Price, D., Harrow, B., Small, M., Pike, J, Higgins, V., 2015, Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, crosssectional survey of US adult asthma patients and physicians. WAO J., 8(1), 26.
  20. Qiu, Y., Zhang, D., Qin, Y., Yin, K.S., 2014, Effect of β2-adrenergic receptor gene Arg16Gly polymorphisms on response to long-acting β2-agonist in Chinese Han asthmatic patients. Multidisciplinary Respiratory Medicine. 22, 1-4
  21. Rahayu, S.A., dan Hamdini, A., 2013. Hubungan tingkat kontrol asma dan kualitas hidup penderita asma yang berobat di RSUD Dr Soedarso Pontianak pada bulan Maret Sampai Mei 2012, Jurnal Fakultas Kedokteran Universitas Tanjungpura, 3(1), 3-12.
  22. Shore, S., dan Drazen, J., 2003, Beta-agonists and asthma: too much of a good thing, Journal of Clinical Investigation, 112(4), 495-7.
  23. Sihombing, M,. Alwi, Q., Nainggolan, O., 2010, Faktor-faktor yang berhubungan dengan penyakit Asma pada usia ≥ 10 tahun di Indonesia (Analisis data riskesdas 2007). Journal Respiratory Indonesia, 30(2), 85-91
  24. Soleimani, F., Fahimi, F., Naghan, P.A., Nadji, S.A., Morowan, S, Naderi, N., dan Masjedi, M.R., 2013, The effect of eolymorphisms of eeta2 adrenoceptors on reponse to long-acting beta2 Agonists in Iranian asthmatic patients. Iran J Allergy Asthma Immunol, 12(4), 383-390.
  25. Trent, R.J, Cheong, P.L., Chua, E.W., Kenned, M.A., 2013, Progresing the utilization of pharmacogenetics and pharmacogenomics into clinical care. Pathology, 45(4), 357-370.
  26. Vrieze, A., Pstma, D.S., dan Kerstjens, H.A.M., 2003, Perimenstrual asthma: a syndrome without known cause or cure. J Allergy Clin Immunol, 112(2), 271-282
  27. Yunitasari A, 2013. Hubungan rinosinusitis kronik dengan tingkat kontrol asma. Tesis: Universitas Diponegoro, Semarang.
  28. Yunus, F., 2005. The asthma control test. A new tool to improve the quality of asthma management. Proceeding of Seminar Perhimpunan Dokter Paru Indonesia, Surakarta, 1st ed, Indah Comp, 361.